Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term chemoradiotherapy. Found 19 abstracts

Cahn DB, Handorf EA, Ghiraldi EM, Ristau BT, Geynisman DM, Churilla TM, Horwitz EM, Sobczak ML, Chen DY, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG, Smaldone MC. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer. Cancer. 2017 Nov 15;123(22):4337-45.
Edelman MJ, Hu C, Le QT, Donington JS, D'Souza WD, Dicker AP, Loo BW, Gore EM, Videtic GM, Evans NR, Leach JW, Diehn M, Feigenberg SJ, Chen Y, Paulus R, Bradley JD. Randomized Phase II Study of Preoperative Chemoradiotherapy +/- Panitumumab Followed by Consolidation Chemotherapy in Potentially Operable Locally Advanced (Stage IIIa, N2+) Non-small Cell Lung Cancer: NRG Oncology RTOG 0839. J Thorac Oncol. 2017 Sep;12(9):1413-20.   PMCID: PMC5594738
Huang JF, Zhang FZ, Zou QZ, Zhou LY, Yang B, Chu JJ, Yu JH, Zhang HW, Yuan XP, Tai GM, Liu FJ, Ma CC. Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: preliminary results from a phase II clinical trial. Oncotarget. 2017 Jan 10;8(2):2457-65.
Huang JF, Zhang FZ, Zou QZ, Zhou LY, Yang B, Chu JJ, Yu JH, Zhang HW, Yuan XP, Tai GM, Liu FJ, Ma CC. Induction chemotherapy followed by concurrent chemoradiation and nimotuzumab for locoregionally advanced nasopharyngeal carcinoma: Preliminary results from a phase II clinical trial. Oncotarget. 2017 Jan 10;8(2):2457-65.   PMCID: PMC5356815
Rose TL, Deal AM, Ladoire S, Crehange G, Galsky MD, Rosenberg JE, Bellmunt J, Wimalasingham A, Wong YN, Harshman LC, Chowdhury S, Niegisch G, Liontos M, Yu EY, Pal SK, Chen RC, Wang AZ, Nielsen ME, Smith AB, Milowsky MI. Patterns of Bladder Preservation Therapy Utilization for Muscle-Invasive Bladder Cancer. Bladder cancer (Amsterdam, Netherlands). 2016 Oct 27;2(4):405-13.   PMCID: PMC5181658
Swisher SG, Winter KA, Komaki RU, Ajani JA, Wu TT, Hofstetter WL, Konski AA, Willett CG. A PHASE II STUDY OF A PACLITAXEL-BASED CHEMORADIATION REGIMEN WITH SELECTIVE SURGICAL SALVAGE FOR RESECTABLE LOCOREGIONALLY ADVANCED ESOPHAGEAL CANCER: INITIAL REPORTING OF RTOG 0246. International Journal of Radiation Oncology Biology Physics. 2012 Apr;82(5):1967-72.   PMCID: *
Wong SJ, Winter K, Meropol NJ, Anne PR, Kachnic L, Rashid A, Watson JC, Mitchell E, Pollock J, Lee RJ, Haddock M, Erickson BA, Willett CG. RADIATION THERAPY ONCOLOGY GROUP 0247: A RANDOMIZED PHASE II STUDY OF NEOADJUVANT CAPECITABINE AND IRINOTECAN OR CAPECITABINE AND OXALIPLATIN WITH CONCURRENT RADIOTHERAPY FOR PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER. International Journal of Radiation Oncology Biology Physics. 2012 Mar;82(4):1367-75.   PMCID: PMC3208721
Chun YS, Cooper HS, Cohen SJ, Konski A, Burtness B, Denlinger CS, Astsaturov I, Hall MJ, Hoffman JP. Significance of Pathologic Response to Preoperative Therapy in Pancreatic Cancer. Annals of Surgical Oncology. 2011 Dec;18(13):3601-7.   PMCID: not NIH funded
Fogh SE, Yu A, Kubicek GJ, Scott W, Mitchell E, Rosato EL, Berger AC. DO ELDERLY PATIENTS EXPERIENCE INCREASED PERIOPERATIVE OR POSTOPERATIVE MORBIDITY OR MORTALITY WHEN GIVEN NEOADJUVANT CHEMORADIATION BEFORE ESOPHAGECTOMY?. International Journal of Radiation Oncology Biology Physics. 2011 Aug;80(5):1372-6.   PMCID: not NIH funded
Showalter SL, Rosato EL, Anne PR, Scott W, Mitchell E, Berger AC. Does Diabetes Mellitus Influence Pathologic Complete Response and Tumor Downstaging After Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Cancer? A Two-Institution Report. Journal of surgical oncology. 2010 Jan;101(1):43-6.   PMCID: not NIH funded
Hu W, Ding WJ, Yang HH, Shao MH, Wang BY, Wang JH, Wu SF, Wu SX, Jin LH, Ma CC. Weekly paclitaxel with concurrent radiotherapy followed by adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma. Radiotherapy and Oncology. 2009 Dec;93(3):488-91.
Movsas B, Diratzouian H, Hanlon A, Cooper H, Freedman G, Konski A, Sigurdson E, Hoffman J, Meropol NJ, Weiner LM, Coia L, Lanciano R, Stein J, Kister D, Eisenberg B. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2006 Oct;29(5):435-41.
Pfister DG, Ridge JA. Induction chemotherapy for larynx preservation: Patient selection or therapeutic effect?. JOURNAL OF CLINICAL ONCOLOGY. 2006 Feb;24(4):540-3.
Ang KK, Harris J, Garden AS, Trotti A, Jones CU, Carrascosa L, Cheng JD, Spencer SS, Forastiere A, Weber RS. Concomitant boost radiation plus concurrent cisplatin for advanced head and neck carcinomas: Radiation therapy oncology group phase II trial 99-14. Journal of Clinical Oncology. 2005 May;23(13):3008-15.
Garden AS, Harris J, Vokes EE, Forastiere AA, Ridge JA, Jones C, Horwitz EM, Glisson BS, Nabell L, Cooper JS, Demas W, Gore E. Preliminary results of Radiation Therapy Oncology Group 97-03: A randomized phase II trial of concurrent radiation and chemotherapy for advanced squamous cell carcinomas of the head and neck. Journal of Clinical Oncology. 2004 Jul;22(14):2856-64.
Tanisada K, Teshima T, Ikeda H, Abe M, Owen JB, Hanks GE, Yamashita T, Nishio M, Yamada S, Sakai K, Hiraoka M, Hirokawa Y, Oguchi M, Inoue T. A preliminary outcome analysis of the patterns of care study in Japan for esophageal cancer patients with special reference to age: Non surgery group. International Journal of Radiation Oncology Biology Physics. 2000 Mar 15;46(5):1223-33.
Hoffman JP, Lipsitz S, Pisansky T, Weese JL, Solin L, Benson AB. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An eastern cooperative oncology group study. Journal of Clinical Oncology. 1998 Jan;16(1):317-23.
Hoffman JP, Pendurthi TK, Ross E, Yeung RS. Preoperative radiation therapy and chemotherapy for adenocarcinoma of the pancreas. Hepato-Gastroenterology. 1998 May;45(21):634-7.
Pendurthi TK, Hoffman JP, Ross E, Johnson DE, Eisenberg BL. Preoperative versus postoperative chemoradiation for patients with resected pancreatic adenocarcinoma. American Surgeon. 1998 Jul;64(7):686-92.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term chemoradiotherapy

chemoradiotherapy radiotherapy cancer carcinoma survival head randomized-trial chemotherapy squamous-cell carcinoma chemoradiation surgery fluorouracil Chemotherapy nasopharyngeal carcinoma pancreaticoduodenectomy i Radiation therapy organ preservation induction chemotherapy therapy radiation-therapy irradiation Oncology nimotuzumab long-term survival locally advanced head resection muscle-invasive bladder cancer Transitional cell carcinoma preoperative ii consensus statement radical cystectomy cystectomy preoperative chemoradiation phase-iii trial sphincter preservation group rtog gastric cardia carboplatin Cancer stratification adenocarcinoma survival analyses ductal adenocarcinoma Chemoradiotherapy Rectal preoperative radiotherapy Salvage surgery hyperfractionated radiation Neoadjuvant therapy gastroesophageal junction hydroxyurea complication diabetes mellitus Nasopharyngeal carcinoma mortality Locally advanced capecitabine neck infusion 5-fluorouracil metaanalysis panitumumab temporal trends Chemoradiation neck-cancer altered fractionation dose radiation Radiotherapy computed-tomography resectable adenocarcinoma neoadjuvant chemoradiation expression treatment strategy EGFR antibody dose leucovorin 1987 arlson me-v40-p373 bladder-preservation therapy Neoadjuvant Non-small cell lung cancer rectosigmoid carcinoma Esophageal cancer clinical-trials expert pathological complete response cisplatin rectal carcinoma trial esophagus gemcitabine-based chemoradiation randomized controlled-trial multimodal therapy infusion hyperfractionated boost multimodality tumor radioresponse Esophagectomy institution phase-iii induction gastroesophageal cancer concurrent chemotherapy phase-ii risk ii trial Patterns of Care Study esophageal cancer Elderly comparative effectiveness research dose fractionation
Last updated on Thursday, April 02, 2020